Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and III Rectal Cancer Patients-Reference-Cited by-同舟云学术

Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and III Rectal Cancer Patients

Published:2014-09-27 Issue:11 Volume:106 Page:
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Reimers Marlies S.,Kuppen Peter J. K.,Lee Mark,Lopatin Margarita,Tezcan Haluk,Putter Hein,Clark-Langone Kim,Liefers Gerrit Jan,Shak Steve,van de Velde Cornelis J. H.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/106/11/dju269/17313187/dju269.pdf

Reference32 articles.

1. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands;Kapiteijn;Eur J Surg Oncol,1998

2. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group;Kapiteijn;Eur J Surg,1999

3. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer;Kapiteijn;N Engl J Med,2001

4. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma;Peeters;Ann Surg,2007

5. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial;van;Lancet Oncol,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of precision molecular diagnostic tests for stage II colorectal cancer;Annals of Translational Medicine;2022-12

2. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location;The Oncologist;2019-02-12

3. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2018-07

4. Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib;Clinical Cancer Research;2018-05-17

5. Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization;Surgery;2018-04